Ascendiant Capital Initiates Aldeyra Therapeutics With Buy By: Benzinga via Benzinga December 03, 2014 at 08:45 AM EST Analysts at Ascendiant Capital initiated coverage on Aldeyra Therapeutics (NASDAQ: ALDX) with a Buy rating. The target price for ... Read More >> Related Stocks: Aldeyra Therapeu